Toronto biotech startup Adela raises $60-million from top U.S. investors

Ontario Industry Updates
Written By Doriane Rey

A leading biotechnology startup from Toronto's University Health Network (UHN) has raised US$60-million form some of the biggest U.S. investors in the sector to help develop its cutting-edge cancer detection technology. Adela Inc. is a diagnostic company that aims to identify multiple types of cancers and other conditions with a simple blood test.

Adela.png
Doriane Rey
Previous

Orion Biotechnology Secures $11.5M Series A Financing
Next

Ripple Therapeutics Research on Polymer-Free Drug Delivery Published in Nature Communications